Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
RainBio, a pioneer in ocular gene therapy, focuses on corneal blindness.
CasTag Biosciences specializes in cell biology and regenerative medicine, focusing on revolutionizing the speed of endogenously.
Redbud Labs develops and manufactures MEMS and microfluidics technologies for the life science industry.
Higgs Boson is a health care company.
Virokine Therapeutics is a Biotechnology company.
Aniluxx Biotechnology is a development stage biopharmaceutical company
Arrevus is a Research Triangle Park-based biotech company.
Cereius is a pre-clinical stage company developing novel approaches to treat solid tumour brain metastasis.
Dualogics provides the latest advancements in protein engineering to create a new class of protein based therapies.
North Carolina Biotechnology Center has invested in 57 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
North Carolina Biotechnology Center's top investment sectors include Biotechnology, Health Care, Medical, Manufacturing, Pharmaceutical. The firm invests across 5 different industry categories.
Among tracked funding rounds, Arrevus received $800K in a Grant round. North Carolina Biotechnology Center's total known invested capital is $145.1M.
North Carolina Biotechnology Center's average investment size is $2.8M across its portfolio of 57 companies.
Recent North Carolina Biotechnology Center portfolio additions include RainBIO, CasTag Biosciences, Redbud Labs, Higgs Boson, Virokine Therapeutics. These companies were founded in 2020 or later.